Cell-based Flu Vaccine Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Cell-based Flu Vaccine in global, including the following market information:
Global Cell-based Flu Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cell-based Flu Vaccine Market Sales, 2017-2022, 2023-2028, (M Doses)
Global top five Cell-based Flu Vaccine companies in 2021 (%)
The global Cell-based Flu Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Trivalent Influenza Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cell-based Flu Vaccine include GlaxoSmithKline, Sanofi, Pfizer, MedImmune, LLC, Intravacc, CSL Limited, E. Merck KG, Novartis and Danaher Corporation and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cell-based Flu Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell-based Flu Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Doses)
Global Cell-based Flu Vaccine Market Segment Percentages, by Type, 2021 (%)
Global Cell-based Flu Vaccine Market Segment Percentages, by Application, 2021 (%)
Global Cell-based Flu Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Cell-based Flu Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cell-based Flu Vaccine revenues share in global market, 2021 (%)
Key companies Cell-based Flu Vaccine sales in global market, 2017-2022 (Estimated), (M Doses)
Key companies Cell-based Flu Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Cell-based Flu Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cell-based Flu Vaccine Market Sales, 2017-2022, 2023-2028, (M Doses)
Global top five Cell-based Flu Vaccine companies in 2021 (%)
The global Cell-based Flu Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Trivalent Influenza Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cell-based Flu Vaccine include GlaxoSmithKline, Sanofi, Pfizer, MedImmune, LLC, Intravacc, CSL Limited, E. Merck KG, Novartis and Danaher Corporation and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cell-based Flu Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell-based Flu Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Doses)
Global Cell-based Flu Vaccine Market Segment Percentages, by Type, 2021 (%)
- Trivalent Influenza Vaccine
- Quadrivalent Influenza Vaccine
Global Cell-based Flu Vaccine Market Segment Percentages, by Application, 2021 (%)
- Aldults
- Children
Global Cell-based Flu Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Cell-based Flu Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cell-based Flu Vaccine revenues share in global market, 2021 (%)
Key companies Cell-based Flu Vaccine sales in global market, 2017-2022 (Estimated), (M Doses)
Key companies Cell-based Flu Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- GlaxoSmithKline
- Sanofi
- Pfizer
- MedImmune, LLC
- Intravacc
- CSL Limited
- E. Merck KG
- Novartis
- Danaher Corporation
- SINOVAC
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Cell-based Flu Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell-based Flu Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CELL-BASED FLU VACCINE OVERALL MARKET SIZE
2.1 Global Cell-based Flu Vaccine Market Size: 2021 VS 2028
2.2 Global Cell-based Flu Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Cell-based Flu Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Cell-based Flu Vaccine Players in Global Market
3.2 Top Global Cell-based Flu Vaccine Companies Ranked by Revenue
3.3 Global Cell-based Flu Vaccine Revenue by Companies
3.4 Global Cell-based Flu Vaccine Sales by Companies
3.5 Global Cell-based Flu Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Cell-based Flu Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Cell-based Flu Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cell-based Flu Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Cell-based Flu Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Cell-based Flu Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Cell-based Flu Vaccine Market Size Markets, 2021 & 2028
4.1.2 Trivalent Influenza Vaccine
4.1.3 Quadrivalent Influenza Vaccine
4.2 By Type - Global Cell-based Flu Vaccine Revenue & Forecasts
4.2.1 By Type - Global Cell-based Flu Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Cell-based Flu Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Cell-based Flu Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Cell-based Flu Vaccine Sales & Forecasts
4.3.1 By Type - Global Cell-based Flu Vaccine Sales, 2017-2022
4.3.2 By Type - Global Cell-based Flu Vaccine Sales, 2023-2028
4.3.3 By Type - Global Cell-based Flu Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Cell-based Flu Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Cell-based Flu Vaccine Market Size, 2021 & 2028
5.1.2 Aldults
5.1.3 Children
5.2 By Application - Global Cell-based Flu Vaccine Revenue & Forecasts
5.2.1 By Application - Global Cell-based Flu Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Cell-based Flu Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Cell-based Flu Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Cell-based Flu Vaccine Sales & Forecasts
5.3.1 By Application - Global Cell-based Flu Vaccine Sales, 2017-2022
5.3.2 By Application - Global Cell-based Flu Vaccine Sales, 2023-2028
5.3.3 By Application - Global Cell-based Flu Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Cell-based Flu Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Cell-based Flu Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Cell-based Flu Vaccine Revenue & Forecasts
6.2.1 By Region - Global Cell-based Flu Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Cell-based Flu Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Cell-based Flu Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Cell-based Flu Vaccine Sales & Forecasts
6.3.1 By Region - Global Cell-based Flu Vaccine Sales, 2017-2022
6.3.2 By Region - Global Cell-based Flu Vaccine Sales, 2023-2028
6.3.3 By Region - Global Cell-based Flu Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Cell-based Flu Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Cell-based Flu Vaccine Sales, 2017-2028
6.4.3 US Cell-based Flu Vaccine Market Size, 2017-2028
6.4.4 Canada Cell-based Flu Vaccine Market Size, 2017-2028
6.4.5 Mexico Cell-based Flu Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Cell-based Flu Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Cell-based Flu Vaccine Sales, 2017-2028
6.5.3 Germany Cell-based Flu Vaccine Market Size, 2017-2028
6.5.4 France Cell-based Flu Vaccine Market Size, 2017-2028
6.5.5 U.K. Cell-based Flu Vaccine Market Size, 2017-2028
6.5.6 Italy Cell-based Flu Vaccine Market Size, 2017-2028
6.5.7 Russia Cell-based Flu Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Cell-based Flu Vaccine Market Size, 2017-2028
6.5.9 Benelux Cell-based Flu Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Cell-based Flu Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Cell-based Flu Vaccine Sales, 2017-2028
6.6.3 China Cell-based Flu Vaccine Market Size, 2017-2028
6.6.4 Japan Cell-based Flu Vaccine Market Size, 2017-2028
6.6.5 South Korea Cell-based Flu Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Cell-based Flu Vaccine Market Size, 2017-2028
6.6.7 India Cell-based Flu Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Cell-based Flu Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Cell-based Flu Vaccine Sales, 2017-2028
6.7.3 Brazil Cell-based Flu Vaccine Market Size, 2017-2028
6.7.4 Argentina Cell-based Flu Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Cell-based Flu Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Cell-based Flu Vaccine Sales, 2017-2028
6.8.3 Turkey Cell-based Flu Vaccine Market Size, 2017-2028
6.8.4 Israel Cell-based Flu Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Cell-based Flu Vaccine Market Size, 2017-2028
6.8.6 UAE Cell-based Flu Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Cell-based Flu Vaccine Major Product Offerings
7.1.4 GlaxoSmithKline Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Cell-based Flu Vaccine Major Product Offerings
7.2.4 Sanofi Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Sanofi Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Cell-based Flu Vaccine Major Product Offerings
7.3.4 Pfizer Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 MedImmune, LLC
7.4.1 MedImmune, LLC Corporate Summary
7.4.2 MedImmune, LLC Business Overview
7.4.3 MedImmune, LLC Cell-based Flu Vaccine Major Product Offerings
7.4.4 MedImmune, LLC Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 MedImmune, LLC Key News
7.5 Intravacc
7.5.1 Intravacc Corporate Summary
7.5.2 Intravacc Business Overview
7.5.3 Intravacc Cell-based Flu Vaccine Major Product Offerings
7.5.4 Intravacc Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Intravacc Key News
7.6 CSL Limited
7.6.1 CSL Limited Corporate Summary
7.6.2 CSL Limited Business Overview
7.6.3 CSL Limited Cell-based Flu Vaccine Major Product Offerings
7.6.4 CSL Limited Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 CSL Limited Key News
7.7 E. Merck KG
7.7.1 E. Merck KG Corporate Summary
7.7.2 E. Merck KG Business Overview
7.7.3 E. Merck KG Cell-based Flu Vaccine Major Product Offerings
7.7.4 E. Merck KG Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 E. Merck KG Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Cell-based Flu Vaccine Major Product Offerings
7.8.4 Novartis Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Novartis Key News
7.9 Danaher Corporation
7.9.1 Danaher Corporation Corporate Summary
7.9.2 Danaher Corporation Business Overview
7.9.3 Danaher Corporation Cell-based Flu Vaccine Major Product Offerings
7.9.4 Danaher Corporation Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Danaher Corporation Key News
7.10 SINOVAC
7.10.1 SINOVAC Corporate Summary
7.10.2 SINOVAC Business Overview
7.10.3 SINOVAC Cell-based Flu Vaccine Major Product Offerings
7.10.4 SINOVAC Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 SINOVAC Key News
8 GLOBAL CELL-BASED FLU VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Cell-based Flu Vaccine Production Capacity, 2017-2028
8.2 Cell-based Flu Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Cell-based Flu Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 CELL-BASED FLU VACCINE SUPPLY CHAIN ANALYSIS
10.1 Cell-based Flu Vaccine Industry Value Chain
10.2 Cell-based Flu Vaccine Upstream Market
10.3 Cell-based Flu Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cell-based Flu Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Cell-based Flu Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell-based Flu Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CELL-BASED FLU VACCINE OVERALL MARKET SIZE
2.1 Global Cell-based Flu Vaccine Market Size: 2021 VS 2028
2.2 Global Cell-based Flu Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Cell-based Flu Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Cell-based Flu Vaccine Players in Global Market
3.2 Top Global Cell-based Flu Vaccine Companies Ranked by Revenue
3.3 Global Cell-based Flu Vaccine Revenue by Companies
3.4 Global Cell-based Flu Vaccine Sales by Companies
3.5 Global Cell-based Flu Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Cell-based Flu Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Cell-based Flu Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cell-based Flu Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Cell-based Flu Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Cell-based Flu Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Cell-based Flu Vaccine Market Size Markets, 2021 & 2028
4.1.2 Trivalent Influenza Vaccine
4.1.3 Quadrivalent Influenza Vaccine
4.2 By Type - Global Cell-based Flu Vaccine Revenue & Forecasts
4.2.1 By Type - Global Cell-based Flu Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Cell-based Flu Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Cell-based Flu Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Cell-based Flu Vaccine Sales & Forecasts
4.3.1 By Type - Global Cell-based Flu Vaccine Sales, 2017-2022
4.3.2 By Type - Global Cell-based Flu Vaccine Sales, 2023-2028
4.3.3 By Type - Global Cell-based Flu Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Cell-based Flu Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Cell-based Flu Vaccine Market Size, 2021 & 2028
5.1.2 Aldults
5.1.3 Children
5.2 By Application - Global Cell-based Flu Vaccine Revenue & Forecasts
5.2.1 By Application - Global Cell-based Flu Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Cell-based Flu Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Cell-based Flu Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Cell-based Flu Vaccine Sales & Forecasts
5.3.1 By Application - Global Cell-based Flu Vaccine Sales, 2017-2022
5.3.2 By Application - Global Cell-based Flu Vaccine Sales, 2023-2028
5.3.3 By Application - Global Cell-based Flu Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Cell-based Flu Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Cell-based Flu Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Cell-based Flu Vaccine Revenue & Forecasts
6.2.1 By Region - Global Cell-based Flu Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Cell-based Flu Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Cell-based Flu Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Cell-based Flu Vaccine Sales & Forecasts
6.3.1 By Region - Global Cell-based Flu Vaccine Sales, 2017-2022
6.3.2 By Region - Global Cell-based Flu Vaccine Sales, 2023-2028
6.3.3 By Region - Global Cell-based Flu Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Cell-based Flu Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Cell-based Flu Vaccine Sales, 2017-2028
6.4.3 US Cell-based Flu Vaccine Market Size, 2017-2028
6.4.4 Canada Cell-based Flu Vaccine Market Size, 2017-2028
6.4.5 Mexico Cell-based Flu Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Cell-based Flu Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Cell-based Flu Vaccine Sales, 2017-2028
6.5.3 Germany Cell-based Flu Vaccine Market Size, 2017-2028
6.5.4 France Cell-based Flu Vaccine Market Size, 2017-2028
6.5.5 U.K. Cell-based Flu Vaccine Market Size, 2017-2028
6.5.6 Italy Cell-based Flu Vaccine Market Size, 2017-2028
6.5.7 Russia Cell-based Flu Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Cell-based Flu Vaccine Market Size, 2017-2028
6.5.9 Benelux Cell-based Flu Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Cell-based Flu Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Cell-based Flu Vaccine Sales, 2017-2028
6.6.3 China Cell-based Flu Vaccine Market Size, 2017-2028
6.6.4 Japan Cell-based Flu Vaccine Market Size, 2017-2028
6.6.5 South Korea Cell-based Flu Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Cell-based Flu Vaccine Market Size, 2017-2028
6.6.7 India Cell-based Flu Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Cell-based Flu Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Cell-based Flu Vaccine Sales, 2017-2028
6.7.3 Brazil Cell-based Flu Vaccine Market Size, 2017-2028
6.7.4 Argentina Cell-based Flu Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Cell-based Flu Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Cell-based Flu Vaccine Sales, 2017-2028
6.8.3 Turkey Cell-based Flu Vaccine Market Size, 2017-2028
6.8.4 Israel Cell-based Flu Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Cell-based Flu Vaccine Market Size, 2017-2028
6.8.6 UAE Cell-based Flu Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Cell-based Flu Vaccine Major Product Offerings
7.1.4 GlaxoSmithKline Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Cell-based Flu Vaccine Major Product Offerings
7.2.4 Sanofi Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Sanofi Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Cell-based Flu Vaccine Major Product Offerings
7.3.4 Pfizer Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 MedImmune, LLC
7.4.1 MedImmune, LLC Corporate Summary
7.4.2 MedImmune, LLC Business Overview
7.4.3 MedImmune, LLC Cell-based Flu Vaccine Major Product Offerings
7.4.4 MedImmune, LLC Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 MedImmune, LLC Key News
7.5 Intravacc
7.5.1 Intravacc Corporate Summary
7.5.2 Intravacc Business Overview
7.5.3 Intravacc Cell-based Flu Vaccine Major Product Offerings
7.5.4 Intravacc Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Intravacc Key News
7.6 CSL Limited
7.6.1 CSL Limited Corporate Summary
7.6.2 CSL Limited Business Overview
7.6.3 CSL Limited Cell-based Flu Vaccine Major Product Offerings
7.6.4 CSL Limited Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 CSL Limited Key News
7.7 E. Merck KG
7.7.1 E. Merck KG Corporate Summary
7.7.2 E. Merck KG Business Overview
7.7.3 E. Merck KG Cell-based Flu Vaccine Major Product Offerings
7.7.4 E. Merck KG Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 E. Merck KG Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Cell-based Flu Vaccine Major Product Offerings
7.8.4 Novartis Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Novartis Key News
7.9 Danaher Corporation
7.9.1 Danaher Corporation Corporate Summary
7.9.2 Danaher Corporation Business Overview
7.9.3 Danaher Corporation Cell-based Flu Vaccine Major Product Offerings
7.9.4 Danaher Corporation Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Danaher Corporation Key News
7.10 SINOVAC
7.10.1 SINOVAC Corporate Summary
7.10.2 SINOVAC Business Overview
7.10.3 SINOVAC Cell-based Flu Vaccine Major Product Offerings
7.10.4 SINOVAC Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 SINOVAC Key News
8 GLOBAL CELL-BASED FLU VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Cell-based Flu Vaccine Production Capacity, 2017-2028
8.2 Cell-based Flu Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Cell-based Flu Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 CELL-BASED FLU VACCINE SUPPLY CHAIN ANALYSIS
10.1 Cell-based Flu Vaccine Industry Value Chain
10.2 Cell-based Flu Vaccine Upstream Market
10.3 Cell-based Flu Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cell-based Flu Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Cell-based Flu Vaccine in Global Market
Table 2. Top Cell-based Flu Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Cell-based Flu Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Cell-based Flu Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Cell-based Flu Vaccine Sales by Companies, (M Doses), 2017-2022
Table 6. Global Cell-based Flu Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Cell-based Flu Vaccine Price (2017-2022) & (US$/Dose)
Table 8. Global Manufacturers Cell-based Flu Vaccine Product Type
Table 9. List of Global Tier 1 Cell-based Flu Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell-based Flu Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cell-based Flu Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Cell-based Flu Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Cell-based Flu Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Cell-based Flu Vaccine Sales (M Doses), 2017-2022
Table 15. By Type - Global Cell-based Flu Vaccine Sales (M Doses), 2023-2028
Table 16. By Application – Global Cell-based Flu Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Cell-based Flu Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Cell-based Flu Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Cell-based Flu Vaccine Sales (M Doses), 2017-2022
Table 20. By Application - Global Cell-based Flu Vaccine Sales (M Doses), 2023-2028
Table 21. By Region – Global Cell-based Flu Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Cell-based Flu Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Cell-based Flu Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Cell-based Flu Vaccine Sales (M Doses), 2017-2022
Table 25. By Region - Global Cell-based Flu Vaccine Sales (M Doses), 2023-2028
Table 26. By Country - North America Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Cell-based Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Cell-based Flu Vaccine Sales, (M Doses), 2017-2022
Table 29. By Country - North America Cell-based Flu Vaccine Sales, (M Doses), 2023-2028
Table 30. By Country - Europe Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Cell-based Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Cell-based Flu Vaccine Sales, (M Doses), 2017-2022
Table 33. By Country - Europe Cell-based Flu Vaccine Sales, (M Doses), 2023-2028
Table 34. By Region - Asia Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Cell-based Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Cell-based Flu Vaccine Sales, (M Doses), 2017-2022
Table 37. By Region - Asia Cell-based Flu Vaccine Sales, (M Doses), 2023-2028
Table 38. By Country - South America Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Cell-based Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Cell-based Flu Vaccine Sales, (M Doses), 2017-2022
Table 41. By Country - South America Cell-based Flu Vaccine Sales, (M Doses), 2023-2028
Table 42. By Country - Middle East & Africa Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Cell-based Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Cell-based Flu Vaccine Sales, (M Doses), 2017-2022
Table 45. By Country - Middle East & Africa Cell-based Flu Vaccine Sales, (M Doses), 2023-2028
Table 46. GlaxoSmithKline Corporate Summary
Table 47. GlaxoSmithKline Cell-based Flu Vaccine Product Offerings
Table 48. GlaxoSmithKline Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 49. Sanofi Corporate Summary
Table 50. Sanofi Cell-based Flu Vaccine Product Offerings
Table 51. Sanofi Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Cell-based Flu Vaccine Product Offerings
Table 54. Pfizer Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 55. MedImmune, LLC Corporate Summary
Table 56. MedImmune, LLC Cell-based Flu Vaccine Product Offerings
Table 57. MedImmune, LLC Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 58. Intravacc Corporate Summary
Table 59. Intravacc Cell-based Flu Vaccine Product Offerings
Table 60. Intravacc Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 61. CSL Limited Corporate Summary
Table 62. CSL Limited Cell-based Flu Vaccine Product Offerings
Table 63. CSL Limited Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 64. E. Merck KG Corporate Summary
Table 65. E. Merck KG Cell-based Flu Vaccine Product Offerings
Table 66. E. Merck KG Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 67. Novartis Corporate Summary
Table 68. Novartis Cell-based Flu Vaccine Product Offerings
Table 69. Novartis Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 70. Danaher Corporation Corporate Summary
Table 71. Danaher Corporation Cell-based Flu Vaccine Product Offerings
Table 72. Danaher Corporation Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 73. SINOVAC Corporate Summary
Table 74. SINOVAC Cell-based Flu Vaccine Product Offerings
Table 75. SINOVAC Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 76. Cell-based Flu Vaccine Production Capacity (M Doses) of Key Manufacturers in Global Market, 2020-2022 (M Doses)
Table 77. Global Cell-based Flu Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Cell-based Flu Vaccine Production by Region, 2017-2022 (M Doses)
Table 79. Global Cell-based Flu Vaccine Production by Region, 2023-2028 (M Doses)
Table 80. Cell-based Flu Vaccine Market Opportunities & Trends in Global Market
Table 81. Cell-based Flu Vaccine Market Drivers in Global Market
Table 82. Cell-based Flu Vaccine Market Restraints in Global Market
Table 83. Cell-based Flu Vaccine Raw Materials
Table 84. Cell-based Flu Vaccine Raw Materials Suppliers in Global Market
Table 85. Typical Cell-based Flu Vaccine Downstream
Table 86. Cell-based Flu Vaccine Downstream Clients in Global Market
Table 87. Cell-based Flu Vaccine Distributors and Sales Agents in Global Market
Table 1. Key Players of Cell-based Flu Vaccine in Global Market
Table 2. Top Cell-based Flu Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Cell-based Flu Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Cell-based Flu Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Cell-based Flu Vaccine Sales by Companies, (M Doses), 2017-2022
Table 6. Global Cell-based Flu Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Cell-based Flu Vaccine Price (2017-2022) & (US$/Dose)
Table 8. Global Manufacturers Cell-based Flu Vaccine Product Type
Table 9. List of Global Tier 1 Cell-based Flu Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell-based Flu Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cell-based Flu Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Cell-based Flu Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Cell-based Flu Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Cell-based Flu Vaccine Sales (M Doses), 2017-2022
Table 15. By Type - Global Cell-based Flu Vaccine Sales (M Doses), 2023-2028
Table 16. By Application – Global Cell-based Flu Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Cell-based Flu Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Cell-based Flu Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Cell-based Flu Vaccine Sales (M Doses), 2017-2022
Table 20. By Application - Global Cell-based Flu Vaccine Sales (M Doses), 2023-2028
Table 21. By Region – Global Cell-based Flu Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Cell-based Flu Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Cell-based Flu Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Cell-based Flu Vaccine Sales (M Doses), 2017-2022
Table 25. By Region - Global Cell-based Flu Vaccine Sales (M Doses), 2023-2028
Table 26. By Country - North America Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Cell-based Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Cell-based Flu Vaccine Sales, (M Doses), 2017-2022
Table 29. By Country - North America Cell-based Flu Vaccine Sales, (M Doses), 2023-2028
Table 30. By Country - Europe Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Cell-based Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Cell-based Flu Vaccine Sales, (M Doses), 2017-2022
Table 33. By Country - Europe Cell-based Flu Vaccine Sales, (M Doses), 2023-2028
Table 34. By Region - Asia Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Cell-based Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Cell-based Flu Vaccine Sales, (M Doses), 2017-2022
Table 37. By Region - Asia Cell-based Flu Vaccine Sales, (M Doses), 2023-2028
Table 38. By Country - South America Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Cell-based Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Cell-based Flu Vaccine Sales, (M Doses), 2017-2022
Table 41. By Country - South America Cell-based Flu Vaccine Sales, (M Doses), 2023-2028
Table 42. By Country - Middle East & Africa Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Cell-based Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Cell-based Flu Vaccine Sales, (M Doses), 2017-2022
Table 45. By Country - Middle East & Africa Cell-based Flu Vaccine Sales, (M Doses), 2023-2028
Table 46. GlaxoSmithKline Corporate Summary
Table 47. GlaxoSmithKline Cell-based Flu Vaccine Product Offerings
Table 48. GlaxoSmithKline Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 49. Sanofi Corporate Summary
Table 50. Sanofi Cell-based Flu Vaccine Product Offerings
Table 51. Sanofi Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Cell-based Flu Vaccine Product Offerings
Table 54. Pfizer Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 55. MedImmune, LLC Corporate Summary
Table 56. MedImmune, LLC Cell-based Flu Vaccine Product Offerings
Table 57. MedImmune, LLC Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 58. Intravacc Corporate Summary
Table 59. Intravacc Cell-based Flu Vaccine Product Offerings
Table 60. Intravacc Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 61. CSL Limited Corporate Summary
Table 62. CSL Limited Cell-based Flu Vaccine Product Offerings
Table 63. CSL Limited Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 64. E. Merck KG Corporate Summary
Table 65. E. Merck KG Cell-based Flu Vaccine Product Offerings
Table 66. E. Merck KG Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 67. Novartis Corporate Summary
Table 68. Novartis Cell-based Flu Vaccine Product Offerings
Table 69. Novartis Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 70. Danaher Corporation Corporate Summary
Table 71. Danaher Corporation Cell-based Flu Vaccine Product Offerings
Table 72. Danaher Corporation Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 73. SINOVAC Corporate Summary
Table 74. SINOVAC Cell-based Flu Vaccine Product Offerings
Table 75. SINOVAC Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 76. Cell-based Flu Vaccine Production Capacity (M Doses) of Key Manufacturers in Global Market, 2020-2022 (M Doses)
Table 77. Global Cell-based Flu Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Cell-based Flu Vaccine Production by Region, 2017-2022 (M Doses)
Table 79. Global Cell-based Flu Vaccine Production by Region, 2023-2028 (M Doses)
Table 80. Cell-based Flu Vaccine Market Opportunities & Trends in Global Market
Table 81. Cell-based Flu Vaccine Market Drivers in Global Market
Table 82. Cell-based Flu Vaccine Market Restraints in Global Market
Table 83. Cell-based Flu Vaccine Raw Materials
Table 84. Cell-based Flu Vaccine Raw Materials Suppliers in Global Market
Table 85. Typical Cell-based Flu Vaccine Downstream
Table 86. Cell-based Flu Vaccine Downstream Clients in Global Market
Table 87. Cell-based Flu Vaccine Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Cell-based Flu Vaccine Segment by Type
Figure 2. Cell-based Flu Vaccine Segment by Application
Figure 3. Global Cell-based Flu Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cell-based Flu Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cell-based Flu Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Cell-based Flu Vaccine Sales in Global Market: 2017-2028 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Cell-based Flu Vaccine Revenue in 2021
Figure 9. By Type - Global Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Cell-based Flu Vaccine Price (US$/Dose), 2017-2028
Figure 12. By Application - Global Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Cell-based Flu Vaccine Price (US$/Dose), 2017-2028
Figure 15. By Region - Global Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 19. US Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 33. China Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Cell-based Flu Vaccine Production Capacity (M Doses), 2017-2028
Figure 49. The Percentage of Production Cell-based Flu Vaccine by Region, 2021 VS 2028
Figure 50. Cell-based Flu Vaccine Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Cell-based Flu Vaccine Segment by Type
Figure 2. Cell-based Flu Vaccine Segment by Application
Figure 3. Global Cell-based Flu Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cell-based Flu Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cell-based Flu Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Cell-based Flu Vaccine Sales in Global Market: 2017-2028 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Cell-based Flu Vaccine Revenue in 2021
Figure 9. By Type - Global Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Cell-based Flu Vaccine Price (US$/Dose), 2017-2028
Figure 12. By Application - Global Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Cell-based Flu Vaccine Price (US$/Dose), 2017-2028
Figure 15. By Region - Global Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 19. US Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 33. China Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Cell-based Flu Vaccine Production Capacity (M Doses), 2017-2028
Figure 49. The Percentage of Production Cell-based Flu Vaccine by Region, 2021 VS 2028
Figure 50. Cell-based Flu Vaccine Industry Value Chain
Figure 51. Marketing Channels
